Compelling benefit of soluble suppression of tumorigenicity-2 in post-myocardial infarction estimation of risk: The time is right for its routine use in the clinic
- Díez, J.
- Bayes-Genis, A.
Journal:
Journal of the American Heart Association
ISSN: 2047-9980
Year of publication: 2017
Volume: 6
Issue: 10
Type: Editorial
